These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35397138)

  • 1. Ticagrelor versus aspirin 2 years after coronary bypass: Observational analysis from the TARGET trial.
    Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
    J Card Surg; 2022 Jul; 37(7):1969-1977. PubMed ID: 35397138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
    Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
    Contemp Clin Trials; 2018 May; 68():45-51. PubMed ID: 29551675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ticagrelor versus aspirin and vein graft patency after coronary bypass: A randomized trial.
    Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
    J Card Surg; 2022 Mar; 37(3):563-570. PubMed ID: 34961950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of lipoproteins and antiplatelet agents on vein graft patency 1 year after coronary artery bypass grafting.
    Zhu J; Zhu Y; Zhang M; Xue Q; Hu J; Liu H; Wang R; Wang X; Zhao Q
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):1030-1039.e4. PubMed ID: 32359899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.
    Willemsen LM; Janssen PWA; Peper J; Soliman-Hamad MA; van Straten AHM; Klein P; Hackeng CM; Sonker U; Bekker MWA; von Birgelen C; Brouwer MA; van der Harst P; Vlot EA; Deneer VHM; Chan Pin Yin DRPP; Gimbel ME; Beukema KF; Daeter EJ; Kelder JC; Tijssen JGP; Rensing BJWM; van Es HW; Swaans MJ; Ten Berg JM
    Circulation; 2020 Nov; 142(19):1799-1807. PubMed ID: 32862716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
    Zhao Q; Zhu Y; Xu Z; Cheng Z; Mei J; Chen X; Wang X
    JAMA; 2018 Apr; 319(16):1677-1686. PubMed ID: 29710164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery.
    Saw J; Wong GC; Mayo J; Bernstein V; Mancini GB; Ye J; Skarsgard P; Starovoytov A; Cairns J
    Heart; 2016 May; 102(10):763-9. PubMed ID: 26891756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
    Willemsen LM; Janssen PWA; Hackeng CM; Kelder JC; Tijssen JGP; van Straten AHM; Soliman-Hamad MA; Deneer VHM; Daeter EJ; Sonker U; Klein P; Ten Berg JM
    Am Heart J; 2020 Feb; 220():237-245. PubMed ID: 31884246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis.
    Sandner S; Redfors B; Angiolillo DJ; Audisio K; Fremes SE; Janssen PWA; Kulik A; Mehran R; Peper J; Ruel M; Saw J; Soletti GJ; Starovoytov A; Ten Berg JM; Willemsen LM; Zhao Q; Zhu Y; Gaudino M
    JAMA; 2022 Aug; 328(6):554-562. PubMed ID: 35943473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ticagrelor for patients undergoing coronary artery bypass grafting: A meta-analysis of randomized controlled trials.
    Xiang F; Lin Y; Chen B
    Perfusion; 2023 May; 38(4):698-705. PubMed ID: 35403510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial.
    Sandner S; Gaudino M; Redfors B; Angiolillo DJ; Ben-Yehuda O; Bhatt DL; Fremes SE; Lamy A; Marano R; Mehran R; Pocock S; Rao SV; Spertus JA; Weinsaft JW; Wells G; Ruel M
    EuroIntervention; 2024 Mar; 20(5):e322-e328. PubMed ID: 38436365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary: Prevention of saphenous vein graft disease remains elusive.
    Hays NM; Balsam LB
    J Card Surg; 2022 Mar; 37(3):571-573. PubMed ID: 34981862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ticagrelor with or without aspirin on vein graft outcome 1 year after on-pump and off-pump coronary artery bypass grafting.
    Zhu Y; Xue Q; Zhang M; Hu J; Liu H; Wang R; Wang X; Han L; Zhao Q
    J Thorac Dis; 2020 Sep; 12(9):4915-4923. PubMed ID: 33145065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
    Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
    J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial.
    de Waha A; Sandner S; von Scheidt M; Boening A; Koch-Buettner K; Hammel D; Hambrecht R; Danner BC; Schöndube FA; Goerlach G; Fischlein T; Schmoeckel M; Oberhoffer M; Schulz R; Walther T; Ziegelhöffer T; Knosalla C; Schönrath F; Beyersdorf F; Siepe M; Attmann T; Misfeld M; Mohr FW; Sievers HH; Joost A; Putman LM; Laufer G; Hamm C; Zeymer U; Kastrati A; Radke PW; Lange R; Cremer J; Schunkert H
    Am Heart J; 2016 Sep; 179():69-76. PubMed ID: 27595681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y
    Circulation; 1989 Nov; 80(5):1190-7. PubMed ID: 2680158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of clopidogrel use post coronary artery bypass surgery on graft patency.
    Ebrahimi R; Bakaeen FG; Uberoi A; Ardehali A; Baltz JH; Hattler B; Almassi GH; Wagner TH; Collins JF; Grover FL; Shroyer AL
    Ann Thorac Surg; 2014 Jan; 97(1):15-21. PubMed ID: 24206971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting.
    Gao C; Ren C; Li D; Li L
    Ann Thorac Surg; 2009 Jul; 88(1):59-62. PubMed ID: 19559191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y
    Circulation; 1988 Jun; 77(6):1324-32. PubMed ID: 3286040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of a VA Cooperative study.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Kern KB; Sethi G; Sharma GV; Khuri S
    Circulation; 1994 Mar; 89(3):1138-43. PubMed ID: 8124800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.